Insulting Putin may now land you in jail under a new Russian law

Agencies
March 19, 2019

Moscow, Mar 19: Russian President Vladimir Putin on Monday signed controversial laws that allow courts to fine and briefly jail people for showing disrespect towards authorities, and block media for publishing "fake news".

Putin signed off on the legislation against the advice of human rights activists, who warned the laws amounted to censorship and would be abused to further crack down on freedom of speech.

The law on disrespecting authorities backs punishment for "offending state symbols" and stipulates hefty fines and jail terms of 15 days for repeat offenders.

Another piece of legislation allows authorities to decide what amounts to "fake news" and gives a media watchdog the power to demand an outlet delete the information.

Websites that fail to comply would be blocked.

Fines could reach 1.5 million rubles (over USD 22,700) if the infraction leads to grave consequences like death or rioting.

Rights activists say that since first becoming president in 2000, Putin has gradually crushed freedoms in Russia, muzzling critics and bringing television under control.

The new legislation takes the crackdown on civil society to a whole new level, they say.

Critics say the legislation is vaguely worded and would have large scope for abuse, further complicating the difficult and sometimes deadly work of rights activists and opposition journalists in Russia.

The Kremlin is stepping up media control to counter a fall in Putin's approval rating amid mounting economic trouble, according to activists.

"These new prohibitions and punishments are not just a continuation of the repressive legislative and practical measures that began in 2012," Yuri Dzhibladze, president of the Centre for the Development of Democracy and Human Rights, told AFP.

"This is a completely new level which almost literally repeats the Soviet-era law about 'activities undermining the Soviet system' and 'anti-Soviet campaigning and propaganda'."

The authorities unleashed a major crackdown on dissenters after Putin returned to the Kremlin in 2012 in the face of mass protests.

"From now it will be police that will decide what fake news is and what's not," said Alexander Cherkasov of Memorial, a top rights group.

"This will lead to a violation of civil rights and freedoms."

Moscow on Monday marked the fifth anniversary of Crimea's annexation from Ukraine, a move condemned by the West but celebrated by most Russians.

Mikhail Fedotov, the chairman of the Kremlin's human rights' council, told AFP that the legislation had "numerous flaws" and his group had asked the president to reject it.

Even the usually pliant media criticised the new laws.

"Authorities want people to hate in silence," mass-circulation tabloid Moskovsky Komsomolets wrote ahead of the signing last week.

"The authorities' desire to gag their subjects is a very old, shameful and meaningless desire."

In 2018, Putin was elected to a historic fourth term in office with a record vote share amid increasing international isolation.

But the 66-year-old Russian president's popularity ratings have taken a beating due to a controversial pension age hike and falling living standards as a result of tough Western sanctions over Ukraine and other crises.

Last month Russian lawmakers backed a bill that could cut off the country's internet traffic from servers abroad, which critics say is a possible step towards an isolated network like in North Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 20,2020

Washington, May 20: The United States recorded another 1,536 coronavirus deaths over the past 24 hours, the Johns Hopkins University tracker said.

That figure, tallied as of 8:30 pm (0030 GMT), raises to 91,845 the total number of COVID-19 deaths in the US.

The US tops the global rankings both for the highest death toll and the highest number of infections, with more than 1.5 million cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 2,2020

Paris, Mar 2: A global agency says the spreading new virus could make the world economy shrink this quarter, for the first time since the international financial crisis more than a decade ago.

The Organization for Economic Cooperation and Development says Monday in a special report on the impact of the virus that the world economy is still expected to grow overall this year and rebound next year.

But it lowered its forecasts for global growth in 2020 by half a percentage point, to 2.4 per cent, and said the figure could go as low as 1.5 per cent if the virus lasts long and spreads widely.

The last time world GDP shrank on a quarter-on-quarter basis was at the end of 2008, during the depths of the financial crisis. On a full-year basis, it last shrank in 2009.

The OECD said China's reduced production is hitting Asia particularly hard but also companies around the world that depend on its goods.

It urged governments to act fast to prevent contagion and restore consumer confidence.

The Paris-based OECD, which advises developed economies on policy, said the impact of this virus is much higher than past outbreaks because "the global economy has become substantially more interconnected, and China plays a far greater role in global output, trade, tourism and commodity markets."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.